Join to access to all OVN content. Join for Free
The ULTIMATE Checklist for New MSLs
MSL Medical Science Liaison Samantha Buckley KOL meetings MSL certification

The ULTIMATE Checklist for New MSLs


Share This Article


Summary

In this episode, Samantha Buckley discusses her journey from clinical pharmacy to becoming an MSL, highlighting the value of personalized cover letters and MSL certification. She delves into territory mapping, strategic planning, and the art of relationship-building as key components of the MSL role. Samantha emphasizes the importance of effective KOL meetings and the insights they provide. She also touches on cross-functional collaboration within Medical Affairs and shares the rewarding aspects of being an MSL. The episode concludes with encouragement for aspiring MSLs and closing remarks.

My guest this week is Samantha Buckley, PharmD. Medical Science Liaison at SOBI who discusses the ultimate checklist for new MSLs.

Learn more about…

πŸ‘‰ The ONE differentiating factor to her MSL job search success
πŸ‘‰ What is day one like for an MSL
πŸ‘‰ Training and certification
πŸ‘‰ The ART of MSLing
πŸ‘‰ Prep for initial KOL meetings

Click for Source
MSL, Medical Science Liaison, Samantha Buckley, KOL meetings, MSL certification

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The Struggle With KOL Access in Todays World
Partner Avatar MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper

The Struggle With KOL Access in Todays World

Podcast
Surround to Succeed: Building a Motivational Network
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

Surround to Succeed: Building a Motivational Network

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN